QR Code

An E3 Aptamer-Modified T Cell-Derived Exosomal Nanoplatform for Codelivery of Astragaloside IV and PESV: Enhancing Prostate Cancer Therapy Through Immune Modulation with Implications for Clinical Translation

Qing Zhang,1 Chenguang Liu,2 Sirui Wu,2 Nan Zhong,2 Junfeng Qiu,3 Wei Fu,4,* Xujun You4,*1Department of General Medicine Center, Shenzhen Bao’an Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, 518133, People’s Republic of China; 2The Seventh...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Zhang Q, Liu C, Wu S, Zhong N, Qiu J, Fu W, You X
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Dove Medical Press 2026-07-01
Rangatū:International Journal of Nanomedicine
Ngā marau:
Prostate cancer
Astragaloside IV-PESV
Exosome delivery system
Antitumor therapy
Tumor microenvironment
Urunga tuihono:https://www.dovepress.com/an-e3-aptamer-modified-t-cell-derived-exosomal-nanoplatform-for-codeli-peer-reviewed-fulltext-article-IJN
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite